The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Efavirenz (EFV), sold under the brand names Sustiva among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.
The global Efavirenz market was valued at US$ 131 million in 2023 and is anticipated to reach US$ 171.9 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Efavirenz, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Efavirenz.
Report Scope
The Efavirenz market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Efavirenz market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Efavirenz manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb
Teva
Mylan
Aurobindo Pharma
Cipla
Macleods Pharmaceuticals
Hetero
Segment by Type
Two-drug combination
Three-drug combination
Segment by Application
Adults
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Efavirenz manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Efavirenz in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Efavirenz (EFV), sold under the brand names Sustiva among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.
The global Efavirenz market was valued at US$ 131 million in 2023 and is anticipated to reach US$ 171.9 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Efavirenz, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Efavirenz.
Report Scope
The Efavirenz market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Efavirenz market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Efavirenz manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb
Teva
Mylan
Aurobindo Pharma
Cipla
Macleods Pharmaceuticals
Hetero
Segment by Type
Two-drug combination
Three-drug combination
Segment by Application
Adults
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Efavirenz manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Efavirenz in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Efavirenz Market Overview
1.1 Product Overview and Scope of Efavirenz
1.2 Efavirenz Segment by Type
1.2.1 Global Efavirenz Market Value Comparison by Type (2024-2030)
1.2.2 Two-drug combination
1.2.3 Three-drug combination
1.3 Efavirenz Segment by Application
1.3.1 Global Efavirenz Market Value by Application: (2024-2030)
1.3.2 Adults
1.3.3 Children
1.4 Global Efavirenz Market Size Estimates and Forecasts
1.4.1 Global Efavirenz Revenue 2019-2030
1.4.2 Global Efavirenz Sales 2019-2030
1.4.3 Global Efavirenz Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Efavirenz Market Competition by Manufacturers
2.1 Global Efavirenz Sales Market Share by Manufacturers (2019-2024)
2.2 Global Efavirenz Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Efavirenz Average Price by Manufacturers (2019-2024)
2.4 Global Efavirenz Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Efavirenz, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Efavirenz, Product Type & Application
2.7 Efavirenz Market Competitive Situation and Trends
2.7.1 Efavirenz Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Efavirenz Players Market Share by Revenue
2.7.3 Global Efavirenz Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Efavirenz Retrospective Market Scenario by Region
3.1 Global Efavirenz Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Efavirenz Global Efavirenz Sales by Region: 2019-2030
3.2.1 Global Efavirenz Sales by Region: 2019-2024
3.2.2 Global Efavirenz Sales by Region: 2025-2030
3.3 Global Efavirenz Global Efavirenz Revenue by Region: 2019-2030
3.3.1 Global Efavirenz Revenue by Region: 2019-2024
3.3.2 Global Efavirenz Revenue by Region: 2025-2030
3.4 North America Efavirenz Market Facts & Figures by Country
3.4.1 North America Efavirenz Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Efavirenz Sales by Country (2019-2030)
3.4.3 North America Efavirenz Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Efavirenz Market Facts & Figures by Country
3.5.1 Europe Efavirenz Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Efavirenz Sales by Country (2019-2030)
3.5.3 Europe Efavirenz Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Efavirenz Market Facts & Figures by Country
3.6.1 Asia Pacific Efavirenz Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Efavirenz Sales by Country (2019-2030)
3.6.3 Asia Pacific Efavirenz Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Efavirenz Market Facts & Figures by Country
3.7.1 Latin America Efavirenz Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Efavirenz Sales by Country (2019-2030)
3.7.3 Latin America Efavirenz Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Efavirenz Market Facts & Figures by Country
3.8.1 Middle East and Africa Efavirenz Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Efavirenz Sales by Country (2019-2030)
3.8.3 Middle East and Africa Efavirenz Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Efavirenz Sales by Type (2019-2030)
4.1.1 Global Efavirenz Sales by Type (2019-2024)
4.1.2 Global Efavirenz Sales by Type (2025-2030)
4.1.3 Global Efavirenz Sales Market Share by Type (2019-2030)
4.2 Global Efavirenz Revenue by Type (2019-2030)
4.2.1 Global Efavirenz Revenue by Type (2019-2024)
4.2.2 Global Efavirenz Revenue by Type (2025-2030)
4.2.3 Global Efavirenz Revenue Market Share by Type (2019-2030)
4.3 Global Efavirenz Price by Type (2019-2030)
5 Segment by Application
5.1 Global Efavirenz Sales by Application (2019-2030)
5.1.1 Global Efavirenz Sales by Application (2019-2024)
5.1.2 Global Efavirenz Sales by Application (2025-2030)
5.1.3 Global Efavirenz Sales Market Share by Application (2019-2030)
5.2 Global Efavirenz Revenue by Application (2019-2030)
5.2.1 Global Efavirenz Revenue by Application (2019-2024)
5.2.2 Global Efavirenz Revenue by Application (2025-2030)
5.2.3 Global Efavirenz Revenue Market Share by Application (2019-2030)
5.3 Global Efavirenz Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Corporation Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb Efavirenz Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol-Myers Squibb Efavirenz Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Efavirenz Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Efavirenz Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Efavirenz Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Efavirenz Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Aurobindo Pharma
6.4.1 Aurobindo Pharma Corporation Information
6.4.2 Aurobindo Pharma Description and Business Overview
6.4.3 Aurobindo Pharma Efavirenz Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aurobindo Pharma Efavirenz Product Portfolio
6.4.5 Aurobindo Pharma Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Corporation Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Efavirenz Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cipla Efavirenz Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Macleods Pharmaceuticals
6.6.1 Macleods Pharmaceuticals Corporation Information
6.6.2 Macleods Pharmaceuticals Description and Business Overview
6.6.3 Macleods Pharmaceuticals Efavirenz Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Macleods Pharmaceuticals Efavirenz Product Portfolio
6.6.5 Macleods Pharmaceuticals Recent Developments/Updates
6.7 Hetero
6.6.1 Hetero Corporation Information
6.6.2 Hetero Description and Business Overview
6.6.3 Hetero Efavirenz Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hetero Efavirenz Product Portfolio
6.7.5 Hetero Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Efavirenz Industry Chain Analysis
7.2 Efavirenz Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Efavirenz Production Mode & Process
7.4 Efavirenz Sales and Marketing
7.4.1 Efavirenz Sales Channels
7.4.2 Efavirenz Distributors
7.5 Efavirenz Customers
8 Efavirenz Market Dynamics
8.1 Efavirenz Industry Trends
8.2 Efavirenz Market Drivers
8.3 Efavirenz Market Challenges
8.4 Efavirenz Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Efavirenz Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Efavirenz Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Efavirenz Market Competitive Situation by Manufacturers in 2023
Table 4. Global Efavirenz Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Efavirenz Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Efavirenz Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Efavirenz Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Efavirenz Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Efavirenz, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Efavirenz, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Efavirenz, Product Type & Application
Table 12. Global Key Manufacturers of Efavirenz, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Efavirenz by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Efavirenz as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Efavirenz Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Efavirenz Sales by Region (2019-2024) & (K Units)
Table 18. Global Efavirenz Sales Market Share by Region (2019-2024)
Table 19. Global Efavirenz Sales by Region (2025-2030) & (K Units)
Table 20. Global Efavirenz Sales Market Share by Region (2025-2030)
Table 21. Global Efavirenz Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Efavirenz Revenue Market Share by Region (2019-2024)
Table 23. Global Efavirenz Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Efavirenz Revenue Market Share by Region (2025-2030)
Table 25. North America Efavirenz Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Efavirenz Sales by Country (2019-2024) & (K Units)
Table 27. North America Efavirenz Sales by Country (2025-2030) & (K Units)
Table 28. North America Efavirenz Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Efavirenz Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Efavirenz Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Efavirenz Sales by Country (2019-2024) & (K Units)
Table 32. Europe Efavirenz Sales by Country (2025-2030) & (K Units)
Table 33. Europe Efavirenz Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Efavirenz Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Efavirenz Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Efavirenz Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Efavirenz Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Efavirenz Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Efavirenz Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Efavirenz Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Efavirenz Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Efavirenz Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Efavirenz Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Efavirenz Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Efavirenz Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Efavirenz Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Efavirenz Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Efavirenz Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Efavirenz Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Efavirenz Sales (K Units) by Type (2019-2024)
Table 51. Global Efavirenz Sales (K Units) by Type (2025-2030)
Table 52. Global Efavirenz Sales Market Share by Type (2019-2024)
Table 53. Global Efavirenz Sales Market Share by Type (2025-2030)
Table 54. Global Efavirenz Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Efavirenz Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Efavirenz Revenue Market Share by Type (2019-2024)
Table 57. Global Efavirenz Revenue Market Share by Type (2025-2030)
Table 58. Global Efavirenz Price (USD/Unit) by Type (2019-2024)
Table 59. Global Efavirenz Price (USD/Unit) by Type (2025-2030)
Table 60. Global Efavirenz Sales (K Units) by Application (2019-2024)
Table 61. Global Efavirenz Sales (K Units) by Application (2025-2030)
Table 62. Global Efavirenz Sales Market Share by Application (2019-2024)
Table 63. Global Efavirenz Sales Market Share by Application (2025-2030)
Table 64. Global Efavirenz Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Efavirenz Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Efavirenz Revenue Market Share by Application (2019-2024)
Table 67. Global Efavirenz Revenue Market Share by Application (2025-2030)
Table 68. Global Efavirenz Price (USD/Unit) by Application (2019-2024)
Table 69. Global Efavirenz Price (USD/Unit) by Application (2025-2030)
Table 70. Bristol-Myers Squibb Corporation Information
Table 71. Bristol-Myers Squibb Description and Business Overview
Table 72. Bristol-Myers Squibb Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Bristol-Myers Squibb Efavirenz Product
Table 74. Bristol-Myers Squibb Recent Developments/Updates
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Teva Efavirenz Product
Table 79. Teva Recent Developments/Updates
Table 80. Mylan Corporation Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Mylan Efavirenz Product
Table 84. Mylan Recent Developments/Updates
Table 85. Aurobindo Pharma Corporation Information
Table 86. Aurobindo Pharma Description and Business Overview
Table 87. Aurobindo Pharma Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Aurobindo Pharma Efavirenz Product
Table 89. Aurobindo Pharma Recent Developments/Updates
Table 90. Cipla Corporation Information
Table 91. Cipla Description and Business Overview
Table 92. Cipla Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Cipla Efavirenz Product
Table 94. Cipla Recent Developments/Updates
Table 95. Macleods Pharmaceuticals Corporation Information
Table 96. Macleods Pharmaceuticals Description and Business Overview
Table 97. Macleods Pharmaceuticals Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Macleods Pharmaceuticals Efavirenz Product
Table 99. Macleods Pharmaceuticals Recent Developments/Updates
Table 100. Hetero Corporation Information
Table 101. Hetero Description and Business Overview
Table 102. Hetero Efavirenz Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Hetero Efavirenz Product
Table 104. Hetero Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Efavirenz Distributors List
Table 108. Efavirenz Customers List
Table 109. Efavirenz Market Trends
Table 110. Efavirenz Market Drivers
Table 111. Efavirenz Market Challenges
Table 112. Efavirenz Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Efavirenz
Figure 2. Global Efavirenz Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Efavirenz Market Share by Type in 2023 & 2030
Figure 4. Two-drug combination Product Picture
Figure 5. Three-drug combination Product Picture
Figure 6. Global Efavirenz Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Efavirenz Market Share by Application in 2023 & 2030
Figure 8. Adults
Figure 9. Children
Figure 10. Global Efavirenz Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Efavirenz Market Size (2019-2030) & (US$ Million)
Figure 12. Global Efavirenz Sales (2019-2030) & (K Units)
Figure 13. Global Efavirenz Average Price (USD/Unit) & (2019-2030)
Figure 14. Efavirenz Report Years Considered
Figure 15. Efavirenz Sales Share by Manufacturers in 2023
Figure 16. Global Efavirenz Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Efavirenz Players: Market Share by Revenue in 2023
Figure 18. Efavirenz Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Efavirenz Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Efavirenz Sales Market Share by Country (2019-2030)
Figure 21. North America Efavirenz Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Efavirenz Sales Market Share by Country (2019-2030)
Figure 25. Europe Efavirenz Revenue Market Share by Country (2019-2030)
Figure 26. Germany Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Efavirenz Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Efavirenz Revenue Market Share by Region (2019-2030)
Figure 33. China Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Efavirenz Sales Market Share by Country (2019-2030)
Figure 44. Latin America Efavirenz Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Efavirenz Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Efavirenz Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Efavirenz Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Efavirenz by Type (2019-2030)
Figure 54. Global Revenue Market Share of Efavirenz by Type (2019-2030)
Figure 55. Global Efavirenz Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Efavirenz by Application (2019-2030)
Figure 57. Global Revenue Market Share of Efavirenz by Application (2019-2030)
Figure 58. Global Efavirenz Price (USD/Unit) by Application (2019-2030)
Figure 59. Efavirenz Value Chain
Figure 60. Efavirenz Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
